Alliancaude e Participacoes (BSP:AALR3) Short-Term Debt: R$237 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:AALR3 Allianca Saude e Participacoes SA BSP:AALR3
48 GF Score
Price R$3.25
GF Value R$9.41
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Alliancaude e Participacoes Short-Term Debt?

Alliancaude e Participacoes BSP:AALR3 +1.56% 48 Short-Term Debt is R$237 Mil as of Sep. 2025. GuruFocus rates BSP:AALR3 with a GF Score™ of 48/100 and a GF Value™ of R$9.41 (Possible Value Trap). The stock has 4 warning signs investors should review.

Alliancaude e Participacoes's Short-Term Debt for the quarter that ended in Sep. 2025 was R$237 Mil.

Alliancaude e Participacoes's quarterly Short-Term Debt declined from Mar. 2025 (R$288 Mil) to Jun. 2025 (R$206 Mil) but then increased from Jun. 2025 (R$206 Mil) to Sep. 2025 (R$237 Mil).

Alliancaude e Participacoes's annual Short-Term Debt declined from Dec. 2022 (R$424 Mil) to Dec. 2023 (R$376 Mil) and declined from Dec. 2023 (R$376 Mil) to Dec. 2024 (R$294 Mil).

Alliancaude e Participacoes Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Alliancaude e Participacoes Short-Term Debt Related Terms

Alliancaude e Participacoes Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Alliancaude e Participacoes's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alliancaude e Participacoes Short-Term Debt Chart

Alliancaude e Participacoes Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 262.98 366.56 424.49 375.98 293.99

Alliancaude e Participacoes Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 240.38 293.99 287.60 206.47 236.91
BSP:AALR3
48GF Score
Allianca Saude e Participacoes SA BSP:AALR3
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of R$237 Mil mean?
Alliancaude e Participacoes (BSP:AALR3) has a Short-Term Debt of R$237 Mil as of Sep. 2025.
Is Alliancaude e Participacoes' Short-Term Debt too high?
Alliancaude e Participacoes' current Short-Term Debt is R$237 Mil. Overall, Alliancaude e Participacoes has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Alliancaude e Participacoes' Short-Term Debt compare to TMO and DHR?
Alliancaude e Participacoes' Short-Term Debt of R$237 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Diagnostics & Research company?
A good Short-Term Debt depends on the Medical Diagnostics & Research industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Alliancaude e Participacoes's current Short-Term Debt is R$237 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alliancaude e Participacoes stock overvalued right now?
Based on GuruFocus' analysis, Alliancaude e Participacoes (BSP:AALR3) is currently considered Possible Value Trap. The stock's GF Value™ is R$9.41, compared to a current price of R$3.25 — trading 65.5% below its estimated fair value. The current Short-Term Debt is R$237 Mil. Alliancaude e Participacoes' overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Alliancaude e Participacoes (BSP:AALR3), the current Short-Term Debt is R$237 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alliancaude e Participacoes (BSP:AALR3) Overvalued in 2026?

Based on GuruFocus' analysis, Alliancaude e Participacoes stock appears to be undervalued. The current stock price of R$3.25 is trading 65.5% below its estimated GF Value™ of R$9.41. GuruFocus considers Alliancaude e Participacoes to be Possible Value Trap.

Key valuation signals for BSP:AALR3:

  • Short-Term Debt: R$237 Mil
  • GF Value™: R$9.41 vs. price of R$3.25 (65.5% below fair value)
  • GF Score™: 48/100 with 4 warning signs

No single metric tells the full story. See the BSP:AALR3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alliancaude e Participacoes Business Description

Address Rua Marselhesa, no. 500, 7th floor, Andar Vila Mariana, Sao Paulo, SP, BRA, 04020-060
Allianca Saude e Participacoes SA formerly Centro de Imagem Diagnosticos SA - Alliar is a diagnostic imaging company consisting of MRI machines, CT scanners and ultrasound machines. Its products include diagnostic medicine, diagnostic imaging and clinical analysis. The company is also engaged in the import of medical and hospital equipment, diagnosis kits, and related goods; Providing health consulting, advisory, courses and lectures.
48GF Score

Get the complete analysis for BSP:AALR3

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$3.25
Price
R$9.41
GF Value